Forecast

There is no analyst data available for this company.

News Go to news feed

Sona Comstar faces family inheritance feud after Sunjay Kapur's sudden death

Sona Comstar is embroiled in a dispute after heir Sunjay Kapur died suddenly in June, with his mother Rani Kapur alleging suspicious circumstances and coerced signatures while the company says she has had no role since 2019. The board proceeded with its AGM and appointed Priya Sachdev as a non-executive director, prompting legal notices and questions over control of the promoters' stake held via the RK Family Trust and Aureus Investments. Experts warn the case highlights broader succession-planning gaps across Indian family-controlled firms. » More on finance.yahoo.com
Sona Comstar plans local magnet production to reduce reliance on China

Sona Comstar, India's largest importer of rare earth magnets, intends to begin domestic manufacturing of magnets used in electric vehicles, responding to government incentives and China's export restrictions. The company, which supplies major automakers and recently diversified into railways, is evaluating investment in local production as it seeks to reduce dependence on Chinese imports. Despite recent leadership changes, Sona Comstar's management affirms its strategic direction remains unchanged. » More on finance.yahoo.com

Financials

In the last quarter, Sona Nanotech had revenue of €0 and net profit of -€397.59K

(EUR)	Apr 2026	YoY
Revenue	0	-
Gross profit	-112.97K	35.25%
Net profit	-397.59K	29.32%
EBITDA	-276.08K	37.05%

Fundamentals

Metric	Value
Market capitalization	€25.18M
Number of shares	114.38M
52-week high/low	€0.51 - €0.16
Dividends	No
Beta	0.99
P/E ratio	-14.67
PEG ratio	-0.90
P/B ratio	-56.86
P/S ratio	0.00

Company profile

Sona Nanotech Inc., ein nanotechnologisches Biowissenschaftsunternehmen, produziert und vertreibt Goldnanorod-Produkte für diagnostische Tests. Das Unternehmen bietet auch den Nanotech COVID-19 Lateral Flow Assay an, einen immunchromatografischen Test zum Nachweis des Spike-Protein-Antigens von SARS-CoV-2 in Speichelproben von Personen, bei denen der Verdacht auf COVID-19 besteht; Gemini-Goldnanostäbchen; Omni-Goldnanostäbchen für medizinische Anwendungen; sowie Vertragsdienstleistungen. Die Produkte des Unternehmens kommen in verschiedenen Bereichen zum Einsatz, u. a. in der Medikamentenverabreichung, bei Lebensmittel- und Getränketests, bei Umwelttests, in der Zellbildgebung, in der Krebsbehandlung und bei der Fettabsaugung sowie in der medizinischen und Verbraucherdiagnostik, im Militär und in der Tiermedizin. Das Unternehmen hat seinen Sitz in Halifax, Kanada.